lumos.png
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
April 14, 2021 16:05 ET | Lumos Pharma, Inc.
AUSTIN, Texas, April 14, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ: LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that it...
PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences selected by Maryland State Medical Society to supply remote patient monitoring and telehealth services
April 13, 2021 16:02 ET | PRA Health Sciences, Inc.
RALEIGH, N.C. and BALTIMORE, April 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) and the Maryland State Medical Society (MedChi) announced today that Care Innovations, a PRA Health...
wpd.jpg
WPD Pharmaceuticals and IAG to Host a Joint Webinar, “The Potential of Advanced Imaging to Show the Early Treatment Effects of Berubicin in Brain Cancer”
April 13, 2021 07:30 ET | WPD Pharmaceuticals
VANCOUVER, British Columbia, April 13, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to...
22157.jpg
Global Pharma, Biotech & Diagnostics Co-promotion and Co-marketing Partnering Terms and Agreements Directory 2021: Comprehensive Access to Records for Over 350 Co-Promotion and Co-Marketing Deals
April 12, 2021 07:43 ET | Research and Markets
Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2021" report has been added to...
TIP_link_300x300.jpg
Microplate Reader Market Value Worth $704.4 Million by 2027, Says The Insight Partners - Impact of COVID-19 Pandemic and Global Analysis
April 08, 2021 12:30 ET | The Insight Partners
Pune, India, April 08, 2021 (GLOBE NEWSWIRE) -- According to our new research study on “Microplate Reader Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type, Application, and...
TIP_link_300x300.jpg
Gastroparesis Market Growth Steady at 4.3% CAGR to Reach $6,025.11 Million by 2027: COVID-19 Impact and Global Analysis by The Insight Partners
April 08, 2021 07:30 ET | The Insight Partners
Pune, India, April 08, 2021 (GLOBE NEWSWIRE) -- According to our new research study on “Gastroparesis Market to 2027 – Global Analysis and Forecast – by Gastroparesis Type, Drug Class Type, and...
logo.jpg.jpg
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Quarter
April 08, 2021 05:00 ET | ViaDerma, Inc.
LOS ANGELES, April 08, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update of estimated sales and revenue numbers for the first quarter of 2021, as...
PRA_StandardLogo_RGB_Pink.png
PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
April 07, 2021 16:01 ET | PRA Health Sciences, Inc.
RALEIGH, N.C. , April 07, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA’s...
TIP_link_300x300.jpg
Anticoagulant Reversal Drugs Market to Garner $2,276.54 Million by 2027 | 12.6% CAGR - Impact of COVID-19 Pandemic and Global Analysis by The Insight Partners
April 07, 2021 10:00 ET | The Insight Partners
Pune, India, April 07, 2021 (GLOBE NEWSWIRE) -- According to our new research study on “Anticoagulant Reversal Drugs Market to 2027 – Global Analysis and Forecast – by Product and Distribution...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports Inducement Grants for New Staff
April 06, 2021 07:00 ET | Recro Pharma, Inc.
MALVERN, Pa., April 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...